Cancer Services Segmentation
The market is segmented by type into blood, breast, ovarian, colposcopy and others, out of which, the breast segment is anticipated to hold a notable share in the market during the forecast period on account of its higher prevalence across the globe. Breast cancer is the most common type of cancer that occurs frequently in females. A report published by World Health Organization (WHO) in 2020 demonstrated that 2.3 million women across the globe were suffering from breast cancer.
Our in-depth analysis of the global market includes the following segments
|
By Diagnosis Procedures |
|
|
By Treatment |
|
|
By Type
|
|
|
By End-User
|
|
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Cancer Services Market size is poised to grow at over 20.4% CAGR during the forecast period i.e., between 2025-2037.
Increasing cases of cancer, a rising geriatric population, and growing consumption of alcohol, cigarettes, and tobacco will boost the market growth.
North America industry is poised to account for largest revenue share by 2037, impelled by higher prevalence of cancer, developing technologies for the treatment and prevention of cancer, and growing healthcare expenditure.
The major players in the market are Siemens Healthcare GmbH, Fonar Corporation, Koninklijke Philips N.V., Shimadzu Corporation, Abbott Laboratories, Samsung Medison Co., Ltd., Eli Lilly and Company, Hologic, Inc., Novartis International AG, and GE Group.
